The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease-Reference-Cited by-同舟云学术

The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease

Published:2005-11-02 Issue:4 Volume:21 Page:500-509
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Castro-Caldas Alexandre,Delwaide Paul,Jost Wolfgang,Merello Marcelo,Williams Adrian,Lamberti Paolo,Aguilar Miguel,Del Signore Susanna,Cesaro Pierre

Funder

Institut de Recherches Internationales Servier, Courbevoie, France

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference43 articles.

1. Long term efficacy of bromocriptine in Parkinson's disease;Lieberman;Neurology,1980

2. The rationale for the use of dopamine agonists in Parkinson's disease;Jenner;Neurology,1995

3. Lisuride in the treatment of parkinsonism;Mc Donald;Eur Neurol,1983

4. Adjuncts to levodopa therapy dopamine agonists;Poewe;Neurology,1998

5. Role of dopaminergic agonists;Rascol;Rev Neurol (Paris),2000

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine agonists in the treatment of Parkinson's disease: the show must go on;Journal of Neural Transmission;2024-09-11

2. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease;Brain Sciences;2024-07-31

3. Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson’s Disease;International Journal of Molecular Sciences;2024-04-24

4. Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease;Current Neuropharmacology;2023-05

5. Parkinson's treatment in perspective. Commentary on Levodopa and dopamine agonists in the treatment of Parkinson's disease by Theodore L. Sourkes and Serge Gauthier;Discoveries in Pharmacology;2023